Benjamin Hudson
About Benjamin Hudson
Benjamin Hudson is an Upstream Process Development Scientist III at Asklepios BioPharmaceutical, Inc. in Durham, North Carolina, with extensive experience in biotech production and a strong background in nucleic acids and technology transfer.
Work at Asklepios BioPharmaceutical
Benjamin Hudson has been employed at Asklepios BioPharmaceutical, Inc. (AskBio) as an Upstream Process Development Scientist III since 2022. His role focuses on upstream bioprocessing, where he applies his expertise in nucleic acids and technology transfer to support the development of gene therapies. Located in Durham, North Carolina, Hudson contributes to the company's mission of advancing innovative biopharmaceutical solutions.
Previous Experience at Duke Human Vaccine Institute
Prior to his current position, Hudson worked at The Duke Human Vaccine Institute. He served as the Cell Line Development Manager from 2021 to 2022 and as an Upstream Process Development Scientist II from 2020 to 2022. In these roles, he was involved in the development of cell lines and upstream processes, enhancing the institute's capabilities in vaccine research and development.
Postdoctoral Fellowship at Washington University
Hudson completed a Postdoctoral Fellowship at Washington University in St. Louis from 2013 to 2017. During this four-year period, he engaged in research that contributed to his foundational knowledge in biochemistry and molecular biology, further developing his skills in bioprocessing and production techniques.
Educational Background
Hudson earned a Bachelor of Science (B.S.) in Chemistry from the University of Central Florida, where he studied from 2004 to 2007. He later obtained a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from Duke University, completing his studies from 2007 to 2012. His educational background provides a strong foundation for his work in the biotechnology sector.
Expertise in Biotech Production
Hudson possesses a robust background in biotech production, with significant experience in upstream bioprocessing. His expertise includes technology transfer in gene editing and cell culture industries. He has held various roles in production, including Senior Production Scientist and Production Supervisor at MilliporeSigma, where he contributed to advancements in bioprocessing techniques.